Using an isogenic panel of cisplatin-resistant NSCLC cell lines, the in vitro re-sensitising capacity of retinoic acid exploitation was assessed across multiple functional parameters, including its effect on the presence of the ALDH1+ve CSC population in cisplatin-resistant lung cancer. Here, ALDH1A1 is linked to non-small cell lung carcinoma.